2,000 Shares in Cabot Co. (NYSE:CBT) Bought by Foundations Investment Advisors LLC

Foundations Investment Advisors LLC bought a new stake in Cabot Co. (NYSE:CBT) during the third quarter, Holdings Channel reports. The institutional investor bought 2,000 shares of the specialty chemicals company’s stock, valued at approximately $224,000.

Several other hedge funds also recently bought and sold shares of the company. BNP Paribas Financial Markets grew its stake in shares of Cabot by 28.8% in the 1st quarter. BNP Paribas Financial Markets now owns 51,271 shares of the specialty chemicals company’s stock valued at $4,727,000 after buying an additional 11,471 shares in the last quarter. Leeward Investments LLC MA lifted its stake in Cabot by 41.1% in the first quarter. Leeward Investments LLC MA now owns 163,617 shares of the specialty chemicals company’s stock valued at $15,085,000 after acquiring an additional 47,682 shares during the last quarter. Janney Montgomery Scott LLC grew its position in Cabot by 125.4% in the first quarter. Janney Montgomery Scott LLC now owns 10,911 shares of the specialty chemicals company’s stock worth $1,006,000 after acquiring an additional 6,070 shares in the last quarter. Sei Investments Co. increased its stake in shares of Cabot by 6.1% during the 1st quarter. Sei Investments Co. now owns 862,081 shares of the specialty chemicals company’s stock worth $79,484,000 after purchasing an additional 49,467 shares during the last quarter. Finally, Assenagon Asset Management S.A. lifted its stake in shares of Cabot by 571.9% in the 2nd quarter. Assenagon Asset Management S.A. now owns 127,116 shares of the specialty chemicals company’s stock valued at $11,681,000 after purchasing an additional 108,197 shares during the last quarter. 93.18% of the stock is owned by institutional investors and hedge funds.

Cabot Trading Down 1.0 %

Cabot stock opened at $109.26 on Friday. The business’s 50-day simple moving average is $107.40 and its 200-day simple moving average is $100.28. Cabot Co. has a 52 week low of $65.10 and a 52 week high of $117.14. The firm has a market capitalization of $6.04 billion, a PE ratio of 13.83, a PEG ratio of 0.93 and a beta of 1.19. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.45 and a current ratio of 2.22.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Monday, August 5th. The specialty chemicals company reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.20. Cabot had a return on equity of 26.99% and a net margin of 12.05%. The company had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1 billion. During the same period in the prior year, the business earned $1.42 earnings per share. Cabot’s revenue for the quarter was up 5.0% compared to the same quarter last year. Equities research analysts forecast that Cabot Co. will post 7.07 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. UBS Group cut their target price on Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a report on Tuesday, August 6th. JPMorgan Chase & Co. boosted their target price on Cabot from $95.00 to $105.00 and gave the stock a “neutral” rating in a report on Wednesday, August 7th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $101.75.

Insiders Place Their Bets

In related news, CEO Sean D. Keohane sold 25,617 shares of Cabot stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the sale, the chief executive officer now directly owns 331,174 shares of the company’s stock, valued at $33,630,719.70. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CFO Erica Mclaughlin sold 23,274 shares of the stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $99.79, for a total value of $2,322,512.46. Following the completion of the transaction, the chief financial officer now owns 59,814 shares in the company, valued at approximately $5,968,839.06. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Sean D. Keohane sold 25,617 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the transaction, the chief executive officer now directly owns 331,174 shares of the company’s stock, valued at $33,630,719.70. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 71,939 shares of company stock worth $7,308,812 in the last ninety days. Insiders own 3.07% of the company’s stock.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.